The main difference between Hodgkin and non-Hodgkin lymphoma

Hodgkin and non-Hodgkin lymphoma are two distinct types of blood cancer that start in lymphocytes—white blood cells that fight infection. The key difference lies in which cells become cancerous and how they behave. In Hodgkin lymphoma, the cancer involves a specific type of abnormal cell called a Reed-Sternberg cell. In non-Hodgkin lymphoma, the cancer develops from other types of lymphocytes and does not produce Reed-Sternberg cells. This difference matters because it changes how doctors treat the disease and what outcomes to expect.

Non-Hodgkin lymphoma is more common, accounting for roughly 90 percent of all lymphoma cases. Hodgkin lymphoma makes up the remaining 10 percent. Both can occur at any age, but they tend to peak at different times in life. Hodgkin lymphoma often appears in people in their 20s or in people over 55, while non-Hodgkin lymphoma becomes more common as people age.

Key Takeaways

  • Hodgkin lymphoma involves Reed-Sternberg cells and tends to spread in an orderly pattern through lymph nodes, while non-Hodgkin lymphoma arises from other lymphocytes and can skip around the body unpredictably.
  • Both types cause similar early symptoms—swollen lymph nodes, fever, night sweats, and fatigue—so a biopsy is the only way to tell them apart.
  • Hodgkin lymphoma generally has better survival rates overall, but non-Hodgkin lymphoma outcomes vary widely depending on the specific subtype and stage at diagnosis.
  • Doctors use imaging scans, blood tests, and a tissue sample from a lymph node to diagnose and stage both types before recommending treatment.
  • Treatment for both types usually involves chemotherapy, radiation, or both, though newer targeted therapies are increasingly used for non-Hodgkin lymphoma.

How the two types spread differently through the body

The way Hodgkin and non-Hodgkin lymphoma spread is one of the most important differences between them. Hodgkin lymphoma tends to move in a predictable, orderly fashion from one group of lymph nodes to the next. If cancer is found in the chest, doctors expect it may have spread to the neck or abdomen in a logical sequence. This pattern makes it easier to predict where the cancer might be and helps doctors plan treatment.

Non-Hodgkin lymphoma behaves unpredictably. It can skip over nearby lymph nodes and appear in distant parts of the body. It may also spread to organs like the liver, bone marrow, or brain, even when nearby lymph nodes are unaffected. This random pattern means doctors must look more carefully throughout the body to find all the cancer, and it affects how they stage and treat the disease.

Symptoms that appear in both types

Early symptoms of Hodgkin and non-Hodgkin lymphoma are nearly identical, which is why a biopsy is essential to tell them apart. The most common sign is swollen lymph nodes—usually in the neck, armpits, or groin—that do not go away after a few weeks. These nodes may be painless or tender to the touch.

Other shared symptoms include fever without an obvious infection, drenching night sweats that soak through clothing, unexplained weight loss, and persistent fatigue. Some people also report itching of the skin. These symptoms can develop slowly over weeks or months, or they may appear more suddenly. Because these signs can point to many different conditions, doctors will not assume lymphoma based on symptoms alone—they need imaging and a tissue sample to confirm.

How doctors diagnose and tell the two types apart

The diagnosis process is the same for both types and always includes a biopsy. If a doctor suspects lymphoma based on symptoms or imaging, they will remove a small sample of tissue from a swollen lymph node, usually under local anesthesia. A pathologist then examines the tissue under a microscope to look for cancer cells and, crucially, to check for Reed-Sternberg cells. The presence of these cells means Hodgkin lymphoma; their absence points toward non-Hodgkin lymphoma.

Before the biopsy, doctors typically order a CT scan or PET scan to see where the swollen nodes are located and whether the cancer has spread to other parts of the body. Blood tests may also be done to check for abnormalities. After the biopsy confirms the type, additional tests help determine the stage—how far the cancer has spread—which guides treatment decisions.

Staging and what it tells you about prognosis

Both Hodgkin and non-Hodgkin lymphoma use the same staging system, which ranges from stage 1 (cancer in one lymph node group) to stage 4 (cancer in multiple organs or bone marrow). Doctors also note whether fever, night sweats, or weight loss are present, which can affect prognosis. Stage and symptoms together help predict how the cancer is likely to behave and what treatment approach will work best.

For Hodgkin lymphoma, stage at diagnosis is a strong predictor of outcome. Early-stage disease (stages 1 and 2) has very high cure rates, often above 90 percent. Even advanced-stage Hodgkin lymphoma responds well to treatment in many cases. For non-Hodgkin lymphoma, prognosis depends heavily on the specific subtype—there are dozens of different kinds, ranging from slow-growing (indolent) to fast-growing (aggressive). A slow-growing non-Hodgkin lymphoma may be monitored without immediate treatment, while an aggressive type requires prompt chemotherapy.

Survival rates and long-term outcomes

Hodgkin lymphoma has one of the best survival rates among cancers. The five-year survival rate—the percentage of people alive five years after diagnosis—is approximately 90 percent overall in the United States. Younger people and those diagnosed at earlier stages have even better outcomes. Many people treated for Hodgkin lymphoma go on to live normal lifespans, though some may experience long-term side effects from chemotherapy or radiation.

Non-Hodgkin lymphoma outcomes vary much more widely because the disease includes many subtypes. Some slow-growing types have five-year survival rates above 80 percent, while aggressive types may be lower if diagnosed at advanced stages. The specific subtype, age at diagnosis, and how well the cancer responds to initial treatment all influence long-term survival. Your doctor can discuss what the statistics mean for your particular situation based on your subtype and stage.

Treatment approaches for each type

Both Hodgkin and non-Hodgkin lymphoma are typically treated with chemotherapy, radiation, or a combination of both. The exact regimen depends on the stage, subtype, and other patient factors. For Hodgkin lymphoma, standard chemotherapy regimens like ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) have been used for decades and remain effective. Radiation may be added, especially for early-stage disease or to treat specific areas where the cancer is bulky.

Non-Hodgkin lymphoma treatment is more varied because the disease is not one condition but many. Slow-growing types may be monitored without treatment initially, a strategy called "watch and wait." When treatment is needed, chemotherapy is common, but newer options like monoclonal antibodies (drugs that target specific proteins on cancer cells) and CAR-T cell therapy (where immune cells are engineered to fight the cancer) are increasingly used. Your oncologist will recommend a treatment plan based on your specific subtype and how advanced the disease is.

Frequently Asked Questions

Can you have both Hodgkin and non-Hodgkin lymphoma at the same time?

This is extremely rare. A person is diagnosed with one type or the other based on the biopsy findings. If a second lymphoma develops later, it would be a separate event, not a simultaneous occurrence of both types.

Does non-Hodgkin lymphoma always require immediate treatment?

No. Slow-growing non-Hodgkin lymphomas may be monitored without treatment for months or years if they are not causing symptoms or spreading rapidly. Aggressive types usually require prompt treatment. Your doctor will discuss whether immediate treatment or observation is appropriate for your situation.

What causes someone to develop Hodgkin or non-Hodgkin lymphoma?

The exact cause is not fully understood. Risk factors include a weakened immune system, certain infections (like Epstein-Barr virus), family history, and exposure to certain chemicals. Most people with risk factors never develop lymphoma, and many people who develop it have no known risk factors.

Are there side effects from treatment that last after cancer is gone?

Yes. Chemotherapy and radiation can cause long-term effects like heart problems, secondary cancers, infertility, or fatigue in some people. Your oncology team will monitor you for these effects and discuss ways to manage them. Many people treated for lymphoma live full, active lives after treatment ends.

How often do people need follow-up appointments after treatment?

Follow-up schedules vary based on the type of lymphoma, stage, and how well treatment worked. Initially, appointments may be every few months, then gradually space out to once or twice yearly. Your doctor will create a plan tailored to your situation and explain what signs to watch for between visits.